Virtual Medicinal Product (VMP)
-
Carmustine 7.7mg implant
Name Details
Current Name
Carmustine 7.7mg implant
|
Start Date
05-01-2005
|
End Date
|
Previous Name
Carmustine 7.7mg implants
|
Start Date
16-06-2004
|
End Date
04-01-2005
|
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 1.0
- UDFS UOM
- device
- Unit Dose UOM
- device
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Intralesional
- Form
- Prolonged-release intralesional implant
- Ontology Form/Route
- implant.intralesional
- Non-availability Indicator
- Actual Products Available
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
-
L01AD01
BNF |
Current BNF
08010100
|
Start Date
04-04-2022
|
End Date
|
Previous BNF
08010100
|
Start Date
17-07-2006
|
End Date
03-04-2022
|
SNOMED Codes
Code
|
Start Date
|
End Date
|
7553411000001106 |
16-06-2004 |
|
VMP Ingredients
VMP ingredients table
Carmustine |
Based on Ingredient Substance |
|
7.7 mg |
|
Name
Carmustine
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
7.7
Strength and UOM (Dmr)
Parent Products
-
VTM
Carmustine
-
VMP
(Current) Carmustine 7.7mg implant
Virtual Medicinal Product Pack (VMPP) Information